ARENSIA Exploratory Medicine, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 80,721 |
| 80,721 |
| 7,319 |
| 6,193 |
| 6,193 |
| 100.00 |
| 7.67 |
| 11,965 |
| 51,279 |
| 5 |
| 62,845 |
| 0.14 |
| 4.29 |
| - |
| - |
| 9.07 |
| 7,319 |
| 2023 |
|---|
| 77,330 |
| 77,330 |
| 8,191 |
| 6,961 |
| 6,961 |
| 100.00 |
| 9.00 |
| 18,926 |
| 55,158 |
| 1 |
| 73,689 |
| 0.24 |
| 2.91 |
| - |
| - |
| 10.59 |
| 8,191 |
| 2024 |
|---|
| 72,227 |
| 72,227 |
| 6,566 |
| 5,581 |
| 5,581 |
| 100.00 |
| 7.73 |
| 24,507 |
| 67,049 |
| 1 |
| 91,105 |
| 0.33 |
| 2.74 |
| - |
| - |
| 9.09 |
| 6,566 |
| 2024 |
|---|
| 72,227 |
| 72,227 |
| 6,566 |
| 5,581 |
| 5,581 |
| 100.00 |
| 7.73 |
| 24,507 |
| 67,049 |
| 1 |
| 91,105 |
| 0.33 |
| 2.74 |
| - |
| - |
| 9.09 |
| 6,566 |
Turnover (€)
2024
Turnover (€)
72,227 €-7 % *
Sales per employee (€)
72,227 €-7 % *
Profit before tax (€)
6,566 €-20 % *
Net Profit (€)
5,581 €-20 % *
Profit per employee (€)
5,581 €-20 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
7.73 %-14.11 % *
Equity (€)
24,507 €29 % *
Amounts Payable And Liabilities (€)
67,049 €22 % *
Non-current Assets (€)
1 €0 % *
CurrentAssets (€)
91,105 €24 % *
Working capital requirement
0.33 37.50 % *
Debt-to-equity ratio
2.74 -5.84 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
9.09 %-14.16 % *
EBIT (€)
6,566 €-20 % *
